For many prostate cancer patients, new guidance is confusing

NewsGuard 100/100 Score

The recommendation that fewer men get screened for the disease goes against what many people believe should be appropriate, NPR reports.

NPR: With PSA Testing, The Power Of Anecdote Often Trumps Statistics
Millions of men and their doctors are trying to understand a federal task force's recommendation against routine use of a prostate cancer test called the PSA. The guidance, which came out last week, raises basic questions about how to interpret medical evidence. And what role expert panels should play in how doctors practice. About 70 percent of men over 50 have gotten a PSA blood test. Some are convinced it was a lifesaver (Knox, 5/28).

Reuters: Doctors Disagree On When To Stop PSA Screening
In the new study, researchers at Johns Hopkins School of Medicine in Baltimore looked at how primary care doctors in their university network typically handle the age question. They found, not surprisingly, that practices varied. Of 125 doctors, about one-third said they had no particular age when they stopped recommending PSA screening (Norton, 5/28).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DASH diet may lower the risk of cardiovascular disease in breast cancer survivors